| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $77.1M | $114.4M | $118.4M |
| YoY Revenue Growth % | -32.6% | -3.4% | — |
| Gross Profit | $12.3M | $29.2M | — |
| Gross Margin % | 15.9% | 25.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$15.5M | -$18.1M | -$4.7M |
| Operating Margin % | -20.1% | -15.8% | -3.9% |
| Net Income (GAAP) | -$21.3M | -$20.4M | -$12.0M |
| EBITDA (Normalized) | -$12.9M | -$15.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$10.5M | $6.4M | $6.8M |
| Capital Expenditures (CapEx) | $3.2M | $3.1M | — |
| Free Cash Flow (FCF) | -$13.7M | $3.3M | $6.8M |
| FCF Margin % | -17.8% | 2.9% | 5.8% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $8.6M | $10.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$19.0M | -$8.4M | — |